PENTAZOCINE HYDROCHLORIDE AND ACETAMINOPHEN tablet

País: Estados Unidos

Idioma: inglés

Fuente: NLM (National Library of Medicine)

Cómpralo ahora

Ficha técnica Ficha técnica (SPC)
12-07-2011

Ingredientes activos:

PENTAZOCINE HYDROCHLORIDE (UNII: A36BXO4PPX) (PENTAZOCINE - UNII:RP4A60D26L), ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D)

Disponible desde:

GAVIS Pharmaceuticals, LLC

Designación común internacional (DCI):

PENTAZOCINE HYDROCHLORIDE

Composición:

PENTAZOCINE HYDROCHLORIDE 25 mg

Vía de administración:

ORAL

tipo de receta:

PRESCRIPTION DRUG

indicaciones terapéuticas:

Pentazocine Hydrochloride and Acetaminophen Tablets are indicated for the relief of mild to moderate pain. Pentazocine hydrochloride and acetaminophen tablets are contraindicated in patients who are hypersensitive to either pentazocine or acetaminophen.

Resumen del producto:

Pentazocine Hydrochloride and Acetaminophen Tablets are light blue capsule shaped, tablets debossed “NL” on left side and “670” on right side of bisect and plain on the other side. Bottles of 100 (NDC 43386-670-01). Bottles of 100 (NDC 43386-670-05) Store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F). [See USP.] Dispense in a tight, light-resistant container as defined in the USP. DEA Order Form Required. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Distributed by: GAVIS Pharmaceuticals, LLC Somerset, NJ 08873 GIN-670-02 Rev: 06/2011

Estado de Autorización:

Abbreviated New Drug Application

Ficha técnica

                                PENTAZOCINE HYDROCHLORIDE AND ACETAMINOPHEN - PENTAZOCINE
HYDROCHLORIDE
AND ACETAMINOPHEN TABLET
GAVIS PHARMACEUTICALS, LLC
----------
PENTAZOCINE HYDROCHLORIDE AND ACETAMINOPHEN TABLETS
HEPATOTOXICITY
Pentazocine Hydrochloride and Acetaminophen Tablets contain
acetaminophen and pentazocine
hydrochloride. Acetaminophen has been associated with cases of acute
liver failure, at times resulting
in liver transplant and death. Most of the cases of liver injury are
associated with the use of
acetaminophen at doses that exceed 4000 milligrams per day, and often
involve more than one
acetaminophen-containing product.
DESCRIPTION
Pentazocine Hydrochloride and Acetaminophen Tablets are a combination
of pentazocine
hydrochloride, USP, equivalent to 25 mg base and acetaminophen, USP,
650 mg.
Pentazocine is a member of the benzazocine series (also known as the
benzomorphan series).
Chemically, pentazocine is
(2R*,6R*,11R*)1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-
butenyl)-2,6-methano-3-benzazocin-8-ol, a white, crystalline substance
soluble in acidic aqueous
solutions, and has the following structural formula:
C
H NO HCl M.W. 321.88
Chemically, acetaminophen is Acetamide, _N_-(4-hydroxyphenyl)-, and
has the following structural
formula:
C H NO M.W. 151.16
Pentazocine is an analgesic and acetaminophen is an analgesic and
antipyretic.
Inactive ingredients: colloidal silicon dioxide, FD&C Blue # 1
aluminum lake, microcrystalline
19
27
8
9
2
cellulose, sodium lauryl sulfate, sodium starch glycolate, and stearic
acid.
CLINICAL PHARMACOLOGY
Pentazocine is a Schedule IV opioid analgesic with agonist/antagonist
action which when administered
orally is approximately equivalent on a mg for mg basis in analgesic
effect to codeine.
Acetaminophen is an analgesic and antipyretic.
Pentazocine weakly antagonizes the analgesic effects of morphine,
meperidine, and phenazocine; in
addition, it produces incomplete reversal of cardiovascular,
respiratory, and behavioral depression
induced by morphine and meperidine. Pentazocine has about
                                
                                Leer el documento completo
                                
                            

Buscar alertas relacionadas con este producto